Commercial suit settled through court-annexed mediation. The court found the Settlement Agreement lawful, decreed the suit in its terms, directed refund of full court fees to the plaintiff, and disposed of the suit and pending applications.
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
$~51
MANKIND PHARMA LIMITED ..... Plaintiff
Through: Ms. Saumya Bajaj, Advocate.
versus
NISEKIND PHARMA PRIVATE LIMITED ..... Defendant
Through: Ms. Harshita Agrawal, Advocate.
CORAM:
HON'BLE MR. JUSTICE SANJEEV NARULA
O R D E R % 03.04.2024
This is a digitally signed order. The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above. The Order is downloaded from the DHC Server on 15/04/2024 at 12:44:53
February, 2024, which shall form part of the decree. Parties shall remain bound by the terms and conditions of the settlement.
SANJEEV NARULA, J
APRIL 3, 2024 as
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above. The Order is downloaded from the DHC Server on 15/04/2024 at 12:44:53
1 issue framed by the court
Whether the suit should be decreed in terms of the settlement agreement dated 20 February 2024 executed between the parties.
Nisekind Pharma Private Limited
Sanjeev Narula
As recorded by the court registry
A suit of a commercial nature above the specified value, governed by the Commercial Courts Act 2015.
Judgements on the same questions, provisions and authorities, from every court
